TERESA ROSSER: Open Payments
NPI 1326691171 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 59 payments from 29 companies in 2025. Trend: 2023 $3,070 · 2024 $2,256 · 2025 $1,293
Food & beverage: $1,293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $113 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Janssen Biotech, Inc. | 5 | $105 |
| PFIZER INC. | 4 | $84 |
| BeOne Medicines USA, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| EMD Serono, Inc. | 2 | $40 |
| Exelixis Inc. | 2 | $38 |
Products named: Enhertu, VENCLEXTA, FRUZAQLA, SCEMBLIX, EPKINLY, LUTATHERA, XTANDI, DARZALEX.
Industry payments across GA — which companies pay providers there.
